|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rossing MA, Wicklund KG, Cushing-Haugen KL
and Weiss NS: Predictive value of symptoms for early detection of
ovarian cancer. J Natl Cancer Inst. 102:222–229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tennant DA, Durán RV and Gottlieb E:
Targeting metabolic transformation for cancer therapy. Nat Rev
Cancer. 10:267–277. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hui S, Ghergurovich JM, Morscher RJ, Jang
C, Teng X, Lu W, Esparza LA, Reya T, Le Zhan, Guo Yanxiang J, et
al: Glucose feeds the TCA cycle via circulating lactate. Nature.
551:115–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
DeBerardinis RJ and Chandel NS:
Fundamentals of cancer metabolism. Sci Adv. 2:e16002002016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirschhaeuser F, Sattler UG and
Mueller-Klieser W: Lactate: A metabolic key player in cancer.
Cancer Res. 71:6921–6925. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Doherty JR and Cleveland JL: Targeting
lactate metabolism for cancer therapeutics. J Clin Invest.
123:3685–3692. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu H, Li X, Luo Z, Liu J and Fan Z:
Cetuximab reverses the Warburg effect by inhibiting HIF-1-regulated
LDH-A. Mol Cancer Ther. 12:2187–2199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao D, Xiong Y, Lei QY and Guan KL: LDH-A
acetylation: Implication in cancer. Oncotarget. 4:802–803. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Zhang X, Wang X, Gan L, Yu G,
Chen Y, Liu K, Li P, Pan J, Wang J, et al: Inhibition of LDH-A by
lentivirus-mediated small interfering RNA suppresses
intestinal-type gastric cancer tumorigenicity through the
downregulation of Oct4. Cancer Lett. 321:45–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Romero-Garcia S, Moreno-Altamirano MM,
Prado-Garcia H and Sánchez-García FJ: Lactate contribution to the
tumor microenvironment: Mechanisms, effects on immune cells and
therapeutic relevance. Front Immunol. 7:522016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou S, Liu R, Yuan K, Yi T, Zhao X, Huang
C and Wei Y: Proteomics analysis of tumor microenvironment:
Implications of metabolic and oxidative stresses in tumorigenesis.
Mass Spectrom Rev. 32:267–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martinez-Outschoorn U, Sotgia F and
Lisanti MP: Tumor microenvironment and metabolic synergy in breast
cancers: Critical importance of mitochondrial fuels and function.
Semin Oncol. 41:195–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Justus CR, Sanderlin EJ and Yang LV:
Molecular connections between cancer cell metabolism and the tumor
microenvironment. Int J Mol Sci. 16:11055–11086. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miranda-Gonçalves V, Granja S, Martinho O,
Honavar M, Pojo M, Costa BM, Pires MM, Pinheiro C, Cordeiro M,
Bebiano G, et al: Hypoxia-mediated upregulation of MCT1 expression
supports the glycolytic phenotype of glioblastomas. Oncotarget.
7:46335–46353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lamb R, Harrison H, Hulit J, Smith DL,
Lisanti MP and Sotgia F: Mitochondria as new therapeutic targets
for eradicating cancer stem cells: Quantitative proteomics and
functional validation via MCT1/2 inhibition. Oncotarget.
5:11029–11037. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Diehl K, Dinges LA, Helm O, Ammar N,
Plundrich D, Arlt A, Röcken C, Sebens S and Schäfer H: Nuclear
factor E2-related factor-2 has a differential impact on MCT1 and
MCT4 lactate carrier expression in colonic epithelial cells: A
condition favoring metabolic symbiosis between colorectal cancer
and stromal cells. Oncogene. 37:39–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong CS, Graham NA, Gu W, Camacho
Espindola C, Mah V, Maresh EL, Alavi M, Bagryanova L, Krotee PA,
Gardner BK, et al: MCT1 modulates cancer cell pyruvate export and
growth of tumors that co-express MCT1 and MCT4. Cell Rep.
14:1590–1601. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Doherty JR, Yang C, Scott KE, Cameron MD,
Fallahi M, Li W, Hall MA, Amelio AL, Mishra JK, Li F, et al:
Blocking lactate export by inhibiting the Myc target MCT1 disables
glycolysis and glutathione synthesis. Cancer Res. 74:908–920. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Halestrap AP and Wilson MC: The
monocarboxylate transporter family-role and regulation. IUBMB Life.
64:109–119. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kakugawa K, Kojo S, Tanaka H, Seo W, Endo
TA, Kitagawa Y, Muroi S, Tenno M, Yasmin N, Kohwi Y, et al:
Essential roles of SATB1 in specifying T lymphocyte subsets. Cell
Rep. 19:1176–1188. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song G, Liu K, Yang X, Mu B, Yang J, He L,
Hu X, Li Q, Zhao Y5, Cai X and Feng G: SATB1 plays an oncogenic
role in esophageal cancer by up-regulation of FN1 and PDGFRB.
Oncotarget. 8:17771–17784. 2017.PubMed/NCBI
|
|
24
|
Wang Y, Gu X, Zhang G, Wang L, Wang T,
Zhao Y, Zhang X, Zhou Y, Kadin M and Tu P: SATB1 overexpression
promotes malignant T-cell proliferation in cutaneous
CD30+ lymphoproliferative disease by repressing p21.
Blood. 123:3452–3461. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiang J, Zhou L, Li S, Xi X, Zhang J, Wang
Y, Yang Y, Liu X and Wan X: AT-rich sequence binding protein 1:
Contribution to tumor progression and metastasis of human ovarian
carcinoma. Oncol Lett. 3:865–870. 2012.PubMed/NCBI
|
|
26
|
Schulze D, Plohmann P, Höbel S and Aigner
A: Anti-tumor effects of fibroblast growth factor-binding protein
(FGF-BP) knockdown in colon carcinoma. Mol Cancer. 10:1442011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stephen TL, Payne KK, Chaurio RA,
Allegrezza MJ, Zhu H, Perez-Sanz J, Perales-Puchalt A, Nguyen JM,
Vara-Ailor AE, Eruslanov EB, et al: SATB1 expression governs
epigenetic repression of PD-1 in tumor-reactive T cells. Immunity.
46:51–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brocato J and Costa M: SATB1 and 2 in
colorectal cancer. Carcinogenesis. 36:186–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mir R, Pradhan SJ, Patil P, Mulherkar R
and Galande S: Wnt/β-catenin signaling regulated SATB1 promotes
colorectal cancer tumorigenesis and progression. Oncogene.
35:1679–1691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Frömberg A, Rabe M, Oppermann H, Gaunitz F
and Aigner A: Analysis of cellular and molecular antitumor effects
upon inhibition of SATB1 in glioblastoma cells. BMC Cancer.
17:32017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao T, Fu L and Jie Z: SATB1
overexpression correlates with gastrointestinal neoplasms invasion
and metastasis: A meta-analysis for Chinese population. Oncotarget.
8:48282–48290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Justus CR, Sanderlin EJ and Yang LV:
Molecular connections between cancer cell metabolism and the tumor
microenvironment. Int J Mol Sci. 16:11055–11086. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang Y, Su D, Zhao L, Zhang D, Xu J, Wan
J, Fan S and Chen M: Different effects of LDH-A inhibition by
oxamate in non-small cell lung cancer cells. Oncotarget.
5:11886–11896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu L, He Y, Ge G, Li L, Zhou P, Zhu Y,
Tang H, Huang Y, Li W and Zhang L: Lactate dehydrogenase and
creatine kinase as poor prognostic factors in lung cancer: A
retrospective observational study. PLoS One. 12:e01821682017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Goff BA, Agnew K, Neradilek MB, Gray HJ,
Liao JB and Urban RR: Combining a symptom index, CA125 and HE4
(triple screen) to detect ovarian cancer in women with a pelvic
mass. Gynecol Oncol. 147:291–295. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiang J, Zhou L, Li X, Bao W, Chen T, Xi
X, He Y and Wan X: Preoperative monocyte-to-lymphocyte ratio in
peripheral blood predicts stages, metastasis, and histological
grades in patients with ovarian cancer. Transl Oncol. 10:33–39.
2017. View Article : Google Scholar : PubMed/NCBI
|
